Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- B of A Securities analyst Tazeen Ahmad downgraded the rating for Sutro Biopharma, Inc. STRO from Buy to Underperform and lowered the price target from $11 to $1. Sutro Biopharma shares closed at $1.25 on Thursday. See how other analysts view this stock.
- Jefferies analyst Matthew Hurwit downgraded Advanced Flower Capital Inc. AFCG from Buy to Hold and slashed the price target from $10 to $7. Advanced Flower Capital shares closed at $6.76 on Thursday. See how other analysts view this stock.
- Stifel analyst Chris O’Cull downgraded Xponential Fitness, Inc. XPOF from Buy to Hold and lowered the price target from $20 to $12. Xponential Fitness shares closed at $12.12 on Thursday. See how other analysts view this stock.
- Citigroup analyst Michael Rollins downgraded the rating for T-Mobile US, Inc. TMUS from Buy to Neutral and announced a $268 price target. T-Mobile US shares closed at $259.10 on Thursday. See how other analysts view this stock.
Considering buying STRO stock? Here’s what analysts think:
Read This Next:
Momentum12.23
Growth–
Quality–
Value–
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
